BIOMARKERS CORE LAB

这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的， 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量， 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 2008年，内分泌核心实验室更名为生物标志物核心实验室，反映了核心实验室提供的额外服务。 核心获得了一个质谱仪与液相色谱和额外的HPLC能力。 Core增加了这项服务，以提供传统免疫分析技术无法提供的小分子和蛋白质组学服务，包括使用电化学检测HPLC检测单胺神经递质。在过去的一年中，核心进一步扩大了其基于质谱的类固醇检测产品和传统的免疫测定菜单，以满足研究者的需求。 生物标志物核心实验室继续为研究人员提供类固醇和蛋白质激素检测服务。 2010年，该实验室为全国58个不同的研究人员提供服务，包括埃默里大学（47%），其他学术机构（43%），政府实验室（3%）和私营企业（7%）。 去年，实验室处理了22，960个样本以支持研究。 通过向所有用户收取费用来收回执行分析所产生的成本，在过去一年中，收回了305，293美元，与2008年和2009年收回的金额相比分别增加了41%和-5%。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. In 2008, the Endocrine Core Lab changed its name to the Biomarkers Core lab, reflecting the added services provided by the Core. The Core acquired a mass spectrometer with liquid chromatography and additional HPLC capabilities. The Core has added this service to provide small molecule and proteomics services that are not available through traditional immunoassay technologies including the detection of monoamine neurotransmitters with electrochemical detection HPLC. Over the past year, the Core has further expanded both its offerings of mass spectrometry based detection of steroids and its traditional immunoassay menu in response to investigator needs. The Biomarkers Core Lab continues to provide steroid and protein hormone assay services for investigators. In 2010, the lab served 58 different investigators located throughout the country, including Emory (47%), other academic institutions (43%), government labs (3%), and private industry (7%). During the last year, the Lab processed 22,960 samples in support of research. Costs incurred in the performance of the assays are recovered using a charge back to all users that, in the past year, resulted in $305,293 recovered, a change of +41 and -5% from the amounts recovered for 2008 and 2009, respectively.